SMC
GBT

S. Muoio & Co’s Global Blood Therapeutics, Inc. GBT Stock Holding History

S. Muoio & Co’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$2.77M Buy
+40,710
New +$2.25M 3.66% 7

Other funds holding GBT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

S. Muoio & Co's GBT Position: Q3 2022 in Review

S. Muoio & Co opened a new position in Global Blood Therapeutics, Inc. (GBT) in Q3 2022: 40,710 shares worth $2.77M. The stake represents 3.66% of the portfolio and ranks #7 among its holdings.

247 funds tracked by Wall St. Rank hold GBT as of Q3 2022.

  • S. Muoio & Co held 40,710 shares of Global Blood Therapeutics, Inc. worth $2.77M as of Q3 2022.
  • Global Blood Therapeutics, Inc. was a new S. Muoio & Co position in Q3 2022.
  • Global Blood Therapeutics, Inc. made up 3.66% of S. Muoio & Co's portfolio in Q3 2022, its #7 holding.
  • 247 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q3 2022.

Based on S. Muoio & Co's 13F filing for Q3 2022, filed 14 Nov 2022.